ProMECE-CytaBOM vs MACOP-B in Advanced Aggressive Non-Hodgkin's Lymphoma: Long Term Results of a Multicenter Study of the Italian Lymphoma Study Group (GISL)Vittorio Silingardi, Caterina Mauri, Luigi Cavanna et al.|Leukemia & lymphoma/Leukemia and lymphoma|1995Cited by 22